Condition

Blood Flow Restriction Therapy clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Blood Flow Restriction Therapy clinical trials that are recruiting, at sites in 3 countries (most in Germany (1), Belgium (1), United States (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Blood Flow Restriction Therapy clinical trials

StudyPhaseWhereStatusRegistered
Blood flow restriction versus standard physical therapy after ankle ligament reconstruction — Lubbock, Texas and 4 other locations Recruiting Mar 5, 2026
Blood flow restriction training for lateral elbow tendinopathy — Munich, Bavaria Recruiting Sep 15, 2025
Blood flow restriction training to improve recovery after Achilles tendon repair — Ghent, East-Flanders and 1 other locations Recruiting Aug 20, 2025

All recruiting trials (3)

Related topics

Achilles Tendon RuptureEpicondylitis of the ElbowLateral EpicondylitisPhysical Therapy

Quick answers

How many Blood Flow Restriction Therapy clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Germany (1 trial), Belgium (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.